| Logo | Name | Σ | Employees |
|---|---|---|---|
 |  Ennogen Our commitment is to provide quality and affordable pharmaceutical products. Ennogen is an international pharmaceutical and medical device company. We aim to reinvigorate heritage brands to meet under-served clinical need. Founded in 2011, we are growing with expanding sales across international markets. Type: | 0 | 38 |
 |  Aurum Biosciences Ltd Imaging life, protecting lives. Aurum Biosciences Ltd is a clinical stage biopharmaceutical company developing novel oxygen carriers for use as therapeutics and diagnostics, initially for Acute Ischaemic Stroke (AIS). Follow-on indications include heart disease, oncology, inflammatory conditions, spinal cord injury, and dementia. Preclinical development has been completed in the lead indication (AIS) and approval has been granted to initiate clinical studies in acute stroke patients. Concurrently, Aurum is pursuing opportunities to develop its pipeline indications with a focus on inflammatory conditions and oncology. Type: | 0 | 5 |
 | Mesenbio Using mesenchymal stem cells to produce therapeutically meaningful extracellular vesicles. We are a recently incorporated limited company, spun out from the University of York from the Genever lab (www.geneverlab.info), which has over 20 years of experience in cell biology and regenerative medicine. We focus on musculoskeletal regeneration using mesenchymal stem cells (MSCs), with a view to translate our body of work into cutting edge therapeutics. Our current focal point is the field of extracellular vesicles (EVs), which have recently gained substantial traction as a next-generation therapeutic modality. We believe that current approaches have room for improvement in terms of consistency … Type: | 3 | 9 |
 | GliaPharm SA Targeting Glial Cells and Brain Metabolism to Treat Neurological Diseases GliaPharm is a Swiss-based biotechnology company that develops treatments for neurological and psychiatric disorders. GliaPharm's innovative therapeutic approach is to target glial cells, the 'support cells' of neurons, to sustain and enhance brain metabolism in pathological conditions. Our vision is to become a leading biotechnology company with a focus on glia-mediated pathways as agents for neuroprotection and maintenance of cognitive functions. Type: | 1 | 11 |
 | Corporis Medical Corporis Medical focuses on the development and commercialization of innovative surgical devices. Corporis Medical is a start-up company that focusses on the development and commercialization of innovative medical devices that improve outcomes of surgical interventions. Our founder is dr. Alexander Veenhof, surgeon at the NKI-AvL who specializes in oncologic surgery in the thorax, esophagus, stomach and adrenal gland. His experiences in the operating room are the inspiration for the devices we develop. We are currently working on bringing two devices to the market: LaprixaTM and MedicloseTM. LaprixaTM is the world’s smallest tissue blood pressure measuring device, which offers the surgeon … Type: | 0 | 15 |
 | Newrotex Ltd UK SME, exploiting the regenerative properties of silk for peripheral nerve repair Newrotex is an Oxford-based SME that has developed an off-the-shelf silk-based conduit for the repair of peripheral nerve injuries. Peripheral Nerve Injury, Silk, Medical Device, Regenerative Medicine, and Biotech Type: | 1 | 7 |
 | KYLYS BIOMOLECULES NOW, FOR YOUR FUTURE KYLYS is a Life Science Spin-off from the University of Geneva, now ready to step into clinical development. Passionate about science and biotechnology, we are committed to developing a unique technology to deliver highly effective and safe products based on the next generation of hyaluronic acid (HA). Our products are aesthetic (KYLYS Aesthetics) and medical (KYLYS). Our technology can revolutionize HA delivery for medical and surgical needs, in the field of: Aesthetic Rheumatology Reconstructive surgery Drug delivery system Veterinary Type: | 0 | 3 |
 | DEBx Medical Innovating the future of wound care DEBx Medical is a leading innovator in advanced wound care solutions, dedicated to transforming the landscape of wound healing. With a focus on removing infection and biofilm, DEBx Medical pioneers groundbreaking solutions to address the unique challenges of hard-to-heal wounds. Medical devices, Healthcare, Infection, Advanced Wound Care, Wound Care, and Biofilm Type: | 0 | 9 |
 | Seamless Therapeutics Seamless Therapeutics is overcoming the boundaries of gene editing by unlocking the full potential of recombinases. Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Our technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes. We are applying our proprietary know-how to develop a pipeline of disease-modifying product candidates across a broad spectrum of indications to expand the therapeutic potential of gene editing. Type: | 1 | 35 |
 |  DP Innovations Ltd. Pulmonary drug delivery with near 100% efficiency DP Innovations Ltd is a privately held healthcare company based in Woodside, CA. The main activity of the company is the development of an innovative pulmonary drug delivery system called SPRIN. SPRIN provides pharmaceutical companies with an alternative delivery system to needle injection for high-precision drugs, such as insulin, gene therapy, antivirals, etc. Type: | 0 | 1 |
 | Diamante Società Benefit Srl Plant-based Nanotechnologies for autoimmune diseases diagnoses and therapy DIAMANTE (Nano-Technologies for Autoimmune Disease) is a biotech company focused on the use of plants for producing high value-added molecules. The company was funded in 2016 with the development of new tools in autoimmune disease diagnosis and now we are growing approaching therapeutics applications. As an innovation-oriented female company, our value proposition is the creation of novel therapeutic approach for autoimmune diseases based on the restoration of self-tolerance, using plant viruses displaying immunodominant peptides. Diamante, thanks to the Regione Veneto and particularly though the national grant POR FESR AZIONE 1.1.1 2020/2021, has … Type: | 0 | 18 |
 | RheoDx Cloud Based Haematology Diagnostics Delivered aaS RheoDx is a diagnostics company committed to improving the quality of life of hematology patients and the efficiency in their clinical management. Develops an inexpensive medical device that monitors red blood cells conditions in less than five minutes with a drop. Its small size and simplicity allow to be used at the point-of-care and at home. Spin-off of the Centre Recerca Matemàtica (CRM), and incorporated in the Collider, the venture builder of tech transfer by Mobile World Capital Foundation. Medical Devices, In vitro diagnostics, Hematology, Point-of-care, Transfusions, and Blood cells conditions Type: | 3 | 2 |
 | fisio360 Physiotherapy centers360 will find specialized attention only by physiotherapists Physio therapy clinics360 put modern facilities at your service with the highest technology and with diploma physiotherapists with extensive experience and continuing training. The philosophy of our center is to do an individualized and personalized treatment, since all pathologies are not equal or all people have the same needs. Physiotherapy, therapeutic massage, osteopathy, and franchise Type: | 0 | 19 |
 | CSV Experts Always Meeting the Standards Computerized Systems Validation Experts. Consultancy services for healthcare regulated companies with regards computerized systems validation in GXP environments. The most valued services delivered in compliance with EU GMP and 21 CFR Part 11. Contact at info@csvexperts.com Strategies for the fulfillment of the GMP and GDP regulations, Strategies for the fulfillment of regulatory needs and quality assurance in the areas of R&D, Medical Devices, IT Compliance, Audits, and Business training Type: | 2 | 8 |
 | Enzymlogic Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. As experts in the generation and interpretation of kinetic data, we pride ourselves on a proven track record of successful partnerships with worldwide organizations of all sizes, supporting them on a routine basis during the early phases of drug discovery. We use exquisitely tuned assays to deliver accurate, robust and reproducible kinetic data of the highest quality that enhances the identification of compounds with the greatest therapeutic potential. The insight … Type: | 4 | 10 |
 | SOM Biotech Biopharmaceutical company focused on the accelerated development of drugs for orphan indications through AI technology SOM Biotech is a biopharmaceutical company focused on the accelerated discovery and development of therapies for orphan indications through a proprietary artificial intelligence-based drug discovery technology and developing strategic partnerships with major research centers and pharmaceutical companies. SOM AI PRO Technology is a proprietary AI-based validated drug discovery technology of SOM Biotech. After defining drug candidates through the technology, we successfully finished the Clinical Phase 2a of two drugs with very positive results. This will contribute to treating two relevant neurodegenerative diseases more effectively, meeting … Type: | 4 | 15 |
 | BioExpert Network Revolutionise science with your knowledge The BioExpert Network, or BEN, is an exclusive network of experts in the sectors of health, biotechnology, life science and investment. Members have the opportunity to access and evaluate funding proposals for innovative research and development projects before anyone else, and help shape the future of life science and medicine. Proposals which receive the most positive evaluations, in terms of innovation, scientific validity, team and business potential have the opportunity to progress to a crowdfunding campaign with Capital Cell, the first online investment platform in Europe specialized in health and biotechnology. PhD level scientists, physicians, … Type: | 1 | 273 |
 | Medyria Smooth and effective cardiovascular procedures Medyria is a Swiss medtech company that engineers technologies for endovascular catheter navigation and sensing. Medyria objective is to make catheter based procedures faster, safer and more effective. Medyria is based In Technopark, Winterthur., Switzerland Medical Devices, EVAR , Technopark Winterthur, and Swiss Startups Type: | 0 | 10 |
 | Drug and Alcohol Testing Institute (DAT Institute) Promote educational opportunities, advance "best practices," and benchmarking opportunities for DER's. Program Managers, Promoting a drug and alcohol-free workplace by advancing professionalism through quality education and best practices. Education, Networking, Regulatory Compliance, Drug Testing, Alcohol Testing, Safety, and Human Resources Type: | 2 | 1 |
 | Spiderwort Biotechnologies Inc. Developing revolutionary biomaterials for regenerative medicine. Spiderwort Inc. is a tissue engineering company specializing in the development of transformative biomaterials for repairing and regenerating tissues within the human body. Type: | 0 | 21 |
 | DTU Health Tech Technology for human health and well-being We develop health technology that makes life better for people. DTU Health Tech educates the engineers of the future, and develop new technology and solutions with a vision to improve people's life before, during and after they are patients. We do this in close collaboration with the health sector, industry, academia and other health partners, because we believe that the best results and ideas often occur in a close collaboration between different sectors. Health technology, Bioinformatics, Biomimetics, Biotherapeutic engineering, Digital health, Drug delivery, Immunology, Hearing research, Magnetic resonance, Medical isotopes, Dosimetry, Optical sensing, Ultrasound, … Type: | 3 | 158 |
 | Clarity Make brain health accessible to everyone, everywhere. Clarity leverages light and sound to pioneer a new category of therapeutics for neurological conditions. Type: | 7 | 15 |
 | Platinum Discovery Multiomics research for precision medicines Platinum Discovery offers a cutting-edge Tumour-to-Target Platform, specialising in cancer vaccine development through the identification of tumour-specific neoantigens. We provide a comprehensive, end-to-end drug discovery pipeline, supporting clinical trial research and translational science for patient samples. Our multidisciplinary team brings together expertise in biology, clinical sciences, multi-omics technologies, bioinformatics, and computational sciences, enabling a deep understanding of the biological processes critical to drug development. We excel at integrating diverse scientific domains to deliver holistic, innovative solutions. With extensive experience in designing and managing complex research programmes, we assemble tailored teams of experts, drawing on our … Type: | 0 | 4 |
 | UroMems UroMems is a biotechnology company based out of 5, rue Raymond Chanas, 38320, Eybens, FRANCE Urologie and Dispositifs médicaux Type: | 14 | 68 |
 | Ambiotis Your partner to resolve inflammation Ambiotis is a pre-clinical CRO specialized in the study of inflammatory processes and the active end of inflammation, called resolution. Resolution is now recognized as the necessary biological process to stop inflammation and restore homeostasis in tissues. This recent approach makes possible to study the inflammation process in a completely innovative and differentiating way. Ambiotis proposes services adapted to pharmaceutical, dermo-cosmetic, agro- food/nutraceutical industries to evaluate the potential of their molecules at preclinical or clinical stages of development. Ambiotis thus helps them to put faster on the market more efficient and innovative compounds on immuno-inflammatory … Type: | 2 | 15 |
 | Air Liquide Medical Systems Air Liquide Medical Systems is the subsidiary of Air Liquide Healthcare that is dedicated to Medical Devices. The company develops, manufactures and sells innovative products in three fields: ventilation (ventilators and patient interfaces for intensive care, emergency care, transport, home), equipment for medical gases and aerosol therapy. We engage for people who strive for life, by inventing the easiest to use device and transforming the standards of care. We engage to offer a better quality of life to patients. Our values are: innovation, simplicity, quality, engagement and team spirit. dispositifs médicaux, ventilateurs, and masques Type: | 9 | 423 |
 | COHESIVES LA REVOLUTION DEEPTECH DU WOUND CARE & SUTURING COHESIVES is a co-development platform for medical devices using our adhesive technology. We are based in DIJON, France. Adhesive, suture, and wound dressing Type: | 6 | 12 |
 | AbilyCare The digital solution to measure one's walk and balance Based on French research, Abilycare was developed by and for practitioners. AbilyCare is a solution that measures walk and balance in order to prevent frailty risks at any moment of our life. It's a medical device (certification in progress), easy and fast to use in order to : - detect early signs of frailty - develop preventive actions to initiate the process of reversibility - monitor the patient's state over time and measure the benefit of a rehabilitation or prevention program Type: | 15 | 7 |
 | Igyxos Igyxos develop more effective/efficient infertility treatment for patients Igyxos is a biotechnology company based out of CENTRE INRAe VAL DE LOIRE SITE DE TOURS, NOUZILLY, France. Biotechnologie, Fertilité, and anticorps monoclonal Type: | 2 | 13 |
 | NOVAMEAT Plant-Based, Reinvented Based in the vibrant city of Barcelona, Novameat provides a range of authentic and sustainable plant-based meats. We simplify conscious choices, empowering people to effortlessly prioritise personal well-being and the future of our planet, without compromising on the gastronomic experience. Led by passionate innovators, we blend expertise in food science, biotechnology, and culinary arts to craft a unique texturising technology, creating nutritious food with an original taste and texture, and a satisfying bite. No soy, no gluten, no complex additives. Only protein-packed goodness. plant-based meat, food tech, cell-cultured meat, microextrusion, food, vegan, alternativeproteins, plantbased, altproteins, wholecuts, foodmanufacturing, foodservice, … Type: | 6 | 39 |
 | Nostrum Biodiscovery Rethink and Accelerate Nostrum Biodiscovery is a spin-off from the Barcelona Supercomputing Center (BSC-CNS) and the Institute for Research in Biomedicine (IRB), two of the most recognized Spanish international research centers. Nostrum Biodiscovery provide advanced technologies in Molecular Modelling, with two areas of focus : therapeutics, e.g. small molecules design, targeted protein degradation, antibodies, immunologics and nucleic acids, and bio-based chemistry as in enzyme engineering. Nostrum Biodiscovery’s customer-tailored solutions are based on state-of-the-art proprietary and 3rd-party software, combined with the latest development on AI. We use best in-class Molecular Modeling for data augmentation and fine-tuning of dedicated machine-learning algorithms. With … Type: | 15 | 38 |
 | Future Port Spreading positive vibes through global tech events and impact awards empowering youth for a better future. Future Port's mission is to present a positive vision of the future, and empower people with a bold mindset, exponential technology, and courage to start building a better tomorrow for everyone, through exciting events and communities. Despite the many challenges world faces today and how it is portrayed by media, we are living in the most extraordinary times in human history. As humankind, we objectively live longer, healthier, richer, and happier lives than ever. More than that, nobody before us had such powerful tools … Type: | 11 | 19 |
 | Spindiag GmbH The infection control solution. Spindiag is a spin-off of Hahn-Schickard, one of the world’s leading research institutions for microsystems technology. Based on its patented microfluidic platform “LabDisk”, Spindiag develops an easy-to-use, compact, and automated point-of-care system for the broad, fast, and affordable screening for respiratory pathogens such as SARS-CoV-2 or drug-resistant pathogens. Behavior guidelines: https://www.spindiag.de/social-media-netiquette/ Impressum Spindiag GmbH Daniel Mark Engesserstr. 4a 79108 Freiburg Germany Email: info@spindiag.de Phone: +49 761 203 73246 Amtsgericht Freiburg im Breisgau HRB 714527 Tax ID number: DE305897842 point-of-care testing and in-vitro diagnostics Type: | 3 | 7 |
 | McSAF Chemical tools for bioconjugaison & biodrugs McSAF is a Deeptech company specialized in Bio-Organic & Bio-Conjugates Chemistry, developing innovative technologies for improved targeted therapies. Its core expertise covers Therapeutic Peptides and Proteins, Antibodies, and Drug Conjugates. The team has a strong background in synthetic selective chemistry, and a real expertise in bioconjugation, including specific designs of Antibody Drug Conjugates (ADCs) with own proprietary coupling technology. Plus, the company has now a pipeline of three products in oncology incorporating McSAF Inside technology with the ambition to bring new biodrugs on the market solving unmet medical needs. Bioconjugation, Biopharmaceuticals, Antibody Drug Conjugates, … Type: | 1 | 6 |
 | ANGANY Biologics of a New Generation to Treat Allergy ANGANY is a private, early clinical stage pharmaceutical company, based in Lévis, QC, Canada. ANGANY has tackled the specific challenges of allergy to invent a novel class of biologics. ANGANY has developed an exclusive therapeutic platform based on synthetic biology: the eBioparticle TM, a self-adjuvant vector bringing novel features of safety and potent immunomodulation to thwart allergy. Type: | 1 | 17 |
 | APTEEUS Reconcile the time of Research with the one of Medecine APTEΞUS was created to provide clinicians and their patients suffering from orphan diseases, an innovative service of clinical biology that perfectly meets the emerging challenge of individualized medicine. APTEΞUS is engaged in patient-centric discovery of individualized treatments. Our technology allows the testing of thousands of molecules directly on primary cells sampled from patient with inborn error of metabolism. We can rapidly identify molecules that specifically correct the very molecular defect of the patient and give him a new opportunity to be cured. Type: | 0 | 5 |
 | Entero Therapeutics (Nasdaq: ENTO) A biopharma company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases Entero Therapeutics, Inc., is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The Company’s programs address significant unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. For more … Type: | 2 | 13 |
 | Neurolixis New treatments for central nervous system disorders Neurolixis Inc. is a biopharmaceutical company focused on the discovery and development of novel drugs for the treatment of human central nervous system diseases including movement disorders, autism spectrum disorders, depression and pain. Neuroscience, Drug development, Rett Syndrome, Parkinson's disease, Biased agonism, and Orphan Drug Type: | 2 | 6 |
 | Adverum Biotechnologies We are on a global mission to establish gene therapy as a new standard of care for the leading causes of vision loss. Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary, intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies, designed to be delivered in physicians’ offices, to eliminate the need for frequent ocular injections to treat these diseases. Adverum is evaluating its … Type: | 0 | 176 |
 | ZEDIRA GmbH Targeting Transglutaminase for Research & Medicine! ZED1227 First Tissue Transglutaminase Inhibitor in Clinical Trials! Zedira is specialist and global brand for transglutaminase. More than 200 specialty reagents for transglutaminase-related R&D. Researchers from academia and industry (including 12 of the top 15 big pharma companies) benefit from Zedira’s cutting edge products – and in an increasing manner – from customised services. Solutions for site specific labeling of proteins using transglutaminases form Zedira’s latest product field. Simply - "The Transglutaminase Company" and From bench to bedside Type: | 1 | 10 |
 | OakLabs Scientific Reach New Heights With Your Biomarkers At OakLabs Scientific, we believe that each of us can live longer healthy. In a society where individual healthcare is increasingly challenging, we are pioneering ways to detect and avert disease before it occurs. Using our unique Artificial Intelligence algorithms and high-molecular-weight data, we are exploring individual health status in unprecedented depth. gene expression analysis, biotechnology, research, biomarkers, biomarker signatures, and companion diagnostics Type: | 1 | 5 |
 | ChromoTek new tools for better research #newtoolsforbetterresearch Part of Proteintech Group. ChromoTek pioneered the development and commercialization of alpaca Nanobodies. As a market and product leader for high quality and reliable Nanobody-based reagents, we assist scientists’ research world-wide. In addition, ChromoTek is a trusted service provider of custom-made Nanobodies for the pharmaceutical industry. Founded in 2008 ChromoTek has offices in Martinsried, Germany, and Hauppauge, NY. In contrast to traditional antibodies Nanobodies consist of only one single polypeptide chain; they are 15 kDa and the smallest antibodies known. ChromoTek GmbH, Affinity purification, Immunoprecipitation, Co-IP, Mass spectrometry, Ligand capture, Protein-protein interaction, GFP-Trap, Fluorescent … Type: | 2 | 16 |
 | Easy Medical Device Consulting Agency. Help you place your Compliant Medical Device on the market Easy Medical Device is a company that will support you to place your Medical Device on the market. With its network, the company is capable of finding you the right support you need to execute your tasks. If you have a project to develop or a problem to solve in terms of Quality and Regulatory Affairs, Easy Medical Device is your solution. We help companies that are bringing new devices on the market or companies that just need an upgrade of their system. We can also find you … Type: | 0 | 15 |
 | VectorBuilder VectorBuilder is a global leader in gene delivery technologies. As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside. VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy. We strive to offer innovative and high-quality products and services while maintaining rapid turnaround and exceptional affordability. Our “white-glove” customer care is supported by a PhD-level team with decades of collective experience to … Type: | 10 | 84 |
 | DBS System Making blood samples travel - not people. DBS System is a medtech company located in the Swiss Health Valley providing advanced technology to collect and prepare blood samples in a less invasive, easier, cheaper, safer manner with precision and industry standard processes. We produce devices with patent pending microfluidic technology capable of plasma/serum extraction and volume control in a standardized and reliable format, dramatically increasing the potential of DBS samples in bioanalysis. The innovative HemaXis platform was developed to combine the power of labs to test and monitor health with people’s desire to stay well. HemaXis will help democratize blood … Type: | 2 | 6 |
 | Kiyatec Inc. Changing the future of cancer care by accurately predicting patient response to therapies before treatment begins Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins. We utilize the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies in our CLIA-certified and research laboratories. Our goal is to enable physicians to isolate only the effective treatments for their patients as quickly as possible - making true personalized medicine a reality. Our approach has been validated through engagements with leading cancer hospitals, multiple top 10 pharmaceutical companies and … Type: | 2 | 19 |
 | Q-linea At Q-linea, we design, develop, and deliver innovative technology to aid physicians and technicians to improve patient outcomes and save lives. We aim to vastly reduce the time to optimal therapy. Q-linea provides infectious disease diagnostics to create sustainable healthcare, now and in the future. For patients, physicians, and society. The company’s leading product, ASTar®, is a fully automated instrument for antimicrobial susceptibility testing, which produces a sensitivity profile from a positive blood culture within approximately six hours. This is 24 to 40 hours faster than current diagnostics. This contributes to reducing the use of broad-spectrum antibiotics. ASTar is CE-IVD … Type: | 0 | 94 |
 | Seres Therapeutics Leading the Microbiome revolution Seres Therapeutics is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Our lead program, VOWSTTM, obtained U.S. FDA approval in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. We are evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation to reduce incidences of gastrointestinal infections, bloodstream infections, and graft-versus-host disease as well as additional preclinical stage programs targeting Infection Protection in … Type: | 3 | 206 |
 | MRM Health Redefining microbiome-based therapeutics MRM Health NV is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome.The company is based in a Center of Expertise for microbiome research and development in the biotech cluster in Ghent, Belgium, and has a strategic partnership with the VIB, with top research groups in both microbiome analysis and ecology and in host biology and disease research. The Company is strategically supported by strong local and international investors, including Ackermans & van Haaren, DuPont, MRM Technologies, Qbic II and VIB and has a corporate collaboration with DuPont Nutrition … Type: | 1 | 42 |
 | MV BioTherapeutics SA A Microbiota biotherapeutics and Vaccines company. Conditioning the gut ecosystem for disease prevention and therapy. Spin-off from the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland, aimed at shaping the intestinal microbiota for the cure and prevention of diseases such as bowel diseases and cancer. The gut ecosystem conditions the function of all our organs and plays a fundamental role in our wellbeing. The mucosal immune system has co-evolved with the intestinal microbiota to adapt its function to a number of environmental and possibly pathogenic factors. MV Bio leverages a microbiota-mediated mechanism regulating the physiological response of the intestinal … Type: | 1 | 1 |
 | OPPILOTECH LTD Navigating Biology, Discovering Drugs Oppilotech have developed a high-resolution platform based on systems biology and machine learning to model biological processes in cells. We use the models to simulate biological processes in order to identify viable drug targets and discover new biology. The company is building a pipeline of first-in-class drug discovery programmes based on the identified targets. Type: | 1 | 11 |
 | PEPperPRINT GmbH The leading provider of high-density peptide microarrays for antibody validation, epitope mapping & antigen discovery. PEPperPRINT is an innovative biotech company from Heidelberg, Germany, and the leading provider of high density peptide and protein microarrays for antibody characterization or the fingerprint analysis of antibody responses from biological samples. The product and service portfolio was recently complemented by T cell epitope mapping and monitoring, making PEPperPRINT a one-stop solution provider for the fingerprint analysis of immune responses e.g. for epitope mapping, antibody biomarker discovery or the analysis of adverse immune effects. PEPperPRINT’s peptide microarrays and screening services have been used by … Type: | 1 | 26 |
 | GQ Bio Therapeutics High-Capacity Gene Therapy Vector Platform to Address Prevalent Diseases GQ Bio is pioneering a high-capacity gene therapy vector platform (HCAd) that addresses some of the big challenges in the gene therapy field: Transfer of large and multiple genes with a single vector, highly efficient gene delivery (high transduction efficiency), and large-scale manufacturability. Based on its HCAd vector platform, GQ Bio develops transformative treatments for chronic, prevalent conditions such as osteoarthritis and intervertebral disc degeneration. GQ Bio is headquartered in Hamburg, Germany and has sites at Luckenwalde (greater Berlin area), Germany and Liège, Belgium. biotechnology, gene therapy, osteoarthritis, drug development, human … Type: | 3 | 19 |
 | Vytrus Biotech Natural Innovation for a Better Life. Applying the real power of plants to cosmetics through biotechnology We create natural active ingredients for skincare and haircare through innovative and sustainable biotechnology processes which obtain the real power of plants. Totipotent Cells Type: | 1 | 38 |
 | NanoSpun Technologies We harness the power of biology to create revolutionary live-active cell-based products and solutions. NanoSpun is a global pioneer and frontrunner in the biotech, advanced materials and bioprinting spaces. We are leading the way to a whole new generation of cell-based products and solutions through the intelligent application of NanoSpun biological fabrics. No other company can do what we do. We encapsulate live and active biological cells and organisms, including bacteria, yeast, algae, plant cells, and mammalian to produce living tissues and fabrics with a wide application across many industries. Our current market focus is to revolutionize Skincare and Bioprocessing. … Type: | 0 | 11 |
 | CIDP - Centre International de Développement Pharmaceutique Naturally Innovative CIDP, Naturally Innovative Established in 2004, CIDP is a private and independent Contract Research Organisation (CRO) that carries out high-performance R&D activities. With over 17 years of experience in the clinical research, CIDP has a strong foothold on each continent with centres located in Brazil, India, Mauritius, and Romania offering an ideal platform for all your research projects worldwide. The services provided by CIDP are segmented into five main areas of expertise: Research & Development activities, Preclinical in vitro testing, Clinical research, Biostatistics and Data Management and Regulatory Affairs. CIDP comprises a team of 130 staff members: doctors, … Type: | 2 | 131 |
 | Stratacuity: Proven Scientific Placement Over 22 years of providing contract & permanent staffing solutions to Bostons Biotech and Pharmaceutical Industries. Stratacuity provides contract and permanent placement, managed services and payroll to top Pharmaceutical and Biopharmaceutical companies. We do it with specific expertise from Discovery to Manufacturing, handling a wide range of scientific skill sets to find your needle-in-the-haystack talent. Stratacuity understands that when companies hire better people the chances of new life-saving therapeutics being discovered and approved increase exponentially. Today, there are many firms handling biotech and pharmaceutical recruiting, but do they embrace the importance of the science their client is developing and how … Type: | 2 | 38 |
 | HAVENTURE Surgical robotics startups Haventure provides legal, quality management and regulatory affairs advice to SMEs in the medical device sector. From quality management, medical compliance and international contract negotiation to human resources management, we accompany our clients in their day-to-day development. Our team of hand-picked experts provides quality, tailored advice and unequaled reactivity. Our experience in the field of medical devices and Augmented Interventions in Medicine spans a period of 25 years and ensures the experience to meet client requirements without delay. In-depth knowledge of the complex regulatory environments and specific obstacles faced by medical companies enables us to anticipate future … Type: | 6 | 30 |
 | GCS ACHATS NOUVELLE AQUITAINE The coordination of regional purchases at the service of health, social and medical and social establishments. 🏆♻ 2023_ Winner of the Purchasing Strategy Prize and implementation of CSR in purchases. [Purchasing crystal] The coordination of regional purchases at the service of health, social and medical and social establishments Purchases, medical devices, drugs, premises maintenance, food, helicoptered health transport, textiles, dasri, and periodic technical controls Type: | 7 | 1 |
 | Nîmes Sport Santé Health through movement Nîmes Sport Santé is an association for the promotion of health through the practice of adapted physical and sporting activity. Since its creation in 2002, the association has become a recognized and unavoidable player in sport-health in Nîmes and its region thanks to its actions intended for people with chronic pathologies, with disabilities, or aging ... Missions: - Improve health and contribute to the physical, mental and social well -being of people by making them practice suitable physical activities. - Promote "sport-health" as an evaluated, organized, individualized and secure approach, using sport as a tool at the … Type: | 0 | 7 |
 | Urgo Medical Make a difference by helping healthcare professionals heal patients Urgo Medical is the wound-healing division of URGO group. Every day our 1600 employees are passionate about creating, developing and promoting highly innovative dressings and global solutions to heal people suffering from wounds. Our mission, as The Healing Company, is to make a significant difference for patients, healthcare professionals and the healthcare systems. In order to fulfil our mission: • Patient is at the heart of everything we do. • We keep innovating to develop the best in class solutions. • We have a pioneer and entrepreneurial mindset and we dare … Type: | 4 | 629 |
 | Ed'Innov Santé Custom-made accompaniment Ed' Innov Saté is a custom training organization, a public health project consulting firm and a creative agency. Ed' Innov Santé supports teams in the optimization of their Care Paths but also in the creation or optimization of Therapeutic Patient Education programs. As a leader in these themes, Ed' Innov santé has, to date, supported more than 250 health establishments with an innovative and highly differentiating approach in Metropolitan France, French overseas departments and territories and French Polynesia (projects in Africa to come). Ed' Innov Santé is an independent organization, regardless of the source of funding, with an … Type: | 6 | 3 |
 | Clinique de l'Escrebieux We take care of you. The Escrebieux clinic is a private establishment of 95 beds which opened in December 1997. Located 5 km from Douai, it is located in the heart of the Artois territory and mainly welcomes patients from the Nord Pas-de-Calais region. It is oriented in the management of anxious and depressive disorders of the adult, man or woman, and in the management of the psychiatric disorders of the subject aged over 65 years. For this, a new unit that welcomed its first patient during the summer of 2015 and dedicated to the Gérono Psychiatrie was fully created. … Type: | 3 | 17 |
 | OMéDIT Centre-Val de Loire Drug observatory💊, medical devices💉, therapeutic innovations🧬 🔎 The omedit Center-Val de Loire is a regional structure of support, evaluation and independent scientific expertise, placed with the ARS. He is strongly involved in the support and implementation of medico -economic quality, safety and efficiency procedures related to medicines and medical devices, with patients and health professionals. In charge of the animation of a coordinated policy of good use of health products and good practices, the omedit participates in the fight against avoidable iatrogenia: ➡️ by disseminating any information on the proper use of health products to all health professionals involved in … Type: | 11 | 8 |
 | OMEDIT Nouvelle-Aquitaine Guadeloupe Guyane Observatory of medication, medical devices and therapeutic innovation Omedit Nouvelle-Aquitaine Guadeloupe and Guyana is a support and expertise structure participating in the Regional Network of Vigilance and Support (RREVA), for the proper use of drugs and medical devices. This regional structure with medico-economic skills supports the development of quality improvement contracts and efficiency of care (CAQES) Type: | 8 | 21 |
 | Centre hospitalier Métropole Savoie - CHMS CHMS is located in Chambéry and Aix-les-Bains. It is the support of GHT Savoie/Belley. Reference establishment for Savoie Belley territory, the Métropole Savoie hospital center is located on two sites in Chambéry and Aix-les-Bains. Each year, the two adult emergency services, pediatric emergencies and gynecological emergencies welcome 24 hours a day over 94,000 patients. The emergency center incorporates the only adult resuscitation service in the territory. Its recent technical tray makes it possible to carry out almost all of the diagnostic and therapeutic acts. All types of surgery are practiced, except cardiac surgery and neurosurgery in 22 block rooms, one … Type: | 5 | 798 |
 | Centre de Santé Mentale Angevin (CESAME) Public Mental Health Establishment-Maine-et-Loire, Pays de la Loire Public mental health establishment, CESAME provides psychiatry care to children, adolescents and adults. The establishment is organized in sectors covering the department of Maine-et-Loire, with the exception of the population of the districts of Cholet and Saumur. Each sector of psychiatry has, apart from the complete hospitalization, of several places of care spread over its territory: medico-psychological center (CMP), part-time therapeutic reception center (CATTP), day-to-day centers or hospitals, therapeutic apartments, permanence places ... At the heart of this system, the CMP occupies a special place. Psychiatry, ambulatory, care, medicine, medico-psychological center, psychological … Type: | 10 | 300 |
 | DÔMES PHARMA Cultivate our positive impact Dômes Pharma is an independent, family-owned company that has been active in the pharmaceutical industry since 1947. It employs 400 people in France, England, Germany, Spain and the USA and has a consolidated turnover of 90 million euros. For over 70 years, the Group has been developing, manufacturing and marketing solutions for the health and well-being of pets. The Dômes Pharma Group has 3 complementary areas of expertise that integrate the entire value chain of medicine and cover all distribution channels. Animal Health Type: | 21 | 140 |
 | THERAVECTYS Based in Paris and in the USA, TheraVectys is an immunotherapy company spun off from the Institut Pasteur created in 2005 by Dr. Pierre Charneau. TheraVectys is pioneering the application of novel lentiviral vector technology to address most of unmet and critical medical needs. By creating the only Joint-Laboratory between a private company and the Institut Pasteur in Paris, TheraVectys develops an extensive pipeline of vaccine candidates to drive the widespread treatment and prevention of cancer and infectious diseases. Leveraging our proprietary technology platform, and the extensive virology expertise of the Institut Pasteur, TheraVectys provides a robust and highly effective … Type: | 2 | 18 |
 | MANDALA International REGULATORY AFFAIRS SPECIALISTS AND REGISTRATION HOLDER MANDALA International offers consulting and operational support for healthcare-related companies seeking to develop their business in Latin America with a special focus on Brazil, Mexico and Colombia. Apart from this, we provide support for CE mark to enter European countries. MANDALA International is the world’s leader for Medical Device & Pharmaceutical Registration in Brazil (ANVISA), Mexico (COFEPRIS), Colombia (INVIMA) and Europe (CE). It is the only service provider authorized to import and distribute drugs in Brazil (Brazilian Registration Holder) and to run an ANVISA-approved laboratory to register pharmaceuticals. MANDALA specializes in the healthcare industry … Type: | 0 | 23 |
 | OMéDIT Normandie Drug observatory, medical devices and therapeutic innovations Omédit Normandie is a regional structure of support, evaluation and independent scientific expertise, placed with the ARS. He is strongly involved in the support and implementation of medico -economic quality, safety and efficiency procedures related to medicines and medical devices, with patients and health professionals. Type: | 6 | 6 |
 | Memo Therapeutics AG Memo Therapeutics AG (“MTx”) is a late-stage biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections and cancer. The Company’s lead program, Potravitug, is in Phase II development targeting BK viremia (BKV) in kidney transplant recipients, an infection which can result in decreased kidney functionality and longevity and reduced patient survival. Potravitug has the potential to become the best and first-in-class BKV disease-modifying therapy for kidney transplant patients. Alongside Potravitug, MTx is focused on discovering novel antibody-target pairs for oncology based on tumor infiltrating B-cells derived leveraging tertiary lymphoid … Type: | 4 | 44 |
 | VarmX VarmX is a young biotech company focusing on the development of therapies in the field of hemostasis and thrombosis. VarmX (www.varmx.com) is a young Leiden based biotech company that is focusing on the development of therapies in the field of hemostasis and thrombosis. Originally a spin-off from the Leiden University Medical Center (LUMC), our mission is to develop and manufacture therapeutic proteins to restore hemostasis. Our lead compound, VMX-C001, is intended to safely and effectively restore hemostasis in case of bleeding or emergency surgery in patients taking so-called oral factor Xa inhibitors. The VarmX program has gained significant interest in … Type: | 1 | 27 |
 | Minervax ApS Developing a maternal vaccine for Group B Streptococcus MinervaX is pursuing the development of a maternal vaccine for the prevention of adverse pregnancy outcomes and life-threating infections caused by Group B streptococcus (GBS). The vaccine is based on adjuvanted proteins antigens covering close to 100% of clinical GBS isolates. Group B Streptococcal (GBS) is the leading cause of life-threatening infections in newborns. Colonization of pregnant women with GBS may lead to adverse pregnancy outcomes such as late abortions, stillbirths, and preterm delivery. Colonization may also lead to life-threatening infections in newborns for the first 3 months of life, causing pneumonia, … Type: | 0 | 67 |
 | Acousia Therapeutics GmbH Enhance & Preserve Natural Hearing ! Acousia is a pioneer of novel medicines. Founded in 2012, the company’s experienced and entrepreneurial management team is committed to combating hearing loss. Thanks to its exclusive collaboration agreement with the renowned Translational Hearing Research Group of Tuebingen University Clinic and an ecosystem of experts and CROs, Acousia has made significant strides with its advanced small molecule drug candidates. Hearing Loss Treatment and Hearing Loss Drug Development Type: | 1 | 5 |
 | Manina Medtech Boosting In Vitro Fertilisation Success Infertility is a global health problem, with a rising incidence, affecting one in every six couples and 190 million people worldwide. In Vitro Fertilisation (IVF), one of the most known infertility treatments, has gained awareness and clients. However, of the nearly a million IVF cycles done in Europe annually, only 40% result in pregnancy. Low IVF success makes the process long, expensive, and emotionally devastating. Manina Medtech is a young startup with a B2B business model and the vision that every woman who goes through IVF requires a single IVF cycle to get pregnant. We … Type: | 1 | 7 |
 | Qorium Real Leather, Reinvented Leather is loved. Leather is luxury. Leather is everywhere. Unfortunately, making leather is also polluting, challenging and controversial. Qorium creates beautiful, premium, and authentic leather without compromise. Cutting-edge science empowers us to dramatically reduce the vast impacts of today’s leather industry without quality reductions. By removing the cow from leather production, Qorium’s material has minimal climate impacts, low water and chemical usage, no land use, and no animal impacts. Simply put, Qorium reinvents leather. Better product. Better planet. Biotechnology, Cell cultured leather, Leather, Cell grown Leather, Sustainable Leather, and Animal free Leather Type: | 5 | 23 |
 | MolDrug Chemoinformatics and modeling solutions to optimize your drug candidates. MolDrug (a ProtoQSAR company) is a group specializing in the design and optimization of molecules through Machine Learning-powered chemoinformatics and structural bioinformatics. Our models allow for the prediction of molecular properties (QSAR) and detailed interaction analyses (molecular modelling). We work with all types of compounds, including small molecules, peptides, nanomaterials, mixtures... Our tools allow for the prediction and assessment of physicochemical, biological, pharmacological, and/or (eco)toxicological properties of substances with an array of advantages: - faster results - saving money and resources - reduce animal testing (3 Rs) - regulatory validity (REACH, … Type: | 0 | 4 |
 | Relation Discovering the relationships at the heart of biology to cure disease. We are an end-to-end biotech developing transformational medicines, with technology at our core. Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of life's most devastating diseases. We leverage single-cell and multi-omics measurements directly from patient tissue, functional assays and machine learning to drive disease understanding — from cause to cure. Medicines born from high-resolution biology, machine learning and clinical insights. Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select … Type: | 14 | 79 |
 | LDMH Partners Life Sciences Advisors. UK | EU | North America We are a niche life sciences advisory firm, and a full service law firm, with exceptional expertise in human tissue- and cell-based research, clinical care, and assisted reproduction. We advise established biotechnology companies as well as start-ups, fertility clinics, and biobanks. medical ethics, data protection, medical law, autonomy, biotechnology, clinical trials, consent, GDPR, Law, and Life sciences law Type: | 0 | 7 |
 | siTOOLs Biotech GmbH High Specificity Tools for RNAi, rRNA depletion & RNA Interactome Studies. Services: Making Sense of RNAi Screening Data We drive RNA research with tailored molecular tools. We are from Munich and provide researchers with highly complex & advanced genetic tools. Our core expertise is RNA interference, bioinformatics, and RNA research tools for RNA-Seq and Ribo-Seq. Distinguished by their exceptional targeting specificity and efficiency, our gene function analysis tools include - siPOOLTM for reliable gene silencing, raPOOLTM for targeted RNA affinity purification and riboPOOLTM for efficient ribosomal RNA depletion. Our technology combines high complexity oligo pooling (“Pack Hunter” approach), proprietary design … Type: | 1 | 10 |
 | CYTENA We make the development of modern therapies faster, safer, and more affordable. Join us to create the future of health! We at CYTENA strive to empower our customers to serve patients faster and better. To accelerate workflows and bring new insights into biotherapeutic drug development, we provide precise control of individual cells through automation and microtechnology. Our instruments offer automated isolation of single cells with assurance of clonality and selection based on cell morphology. We can isolate many common cell types including bacteria. Our high viability rates make our instruments compatible with cell line development, single cell analysis, and other … Type: | 1 | 68 |
 | HP Health Solutions For more information, please visit www.gna-bio.com Laser PCR, Molecular Diagnostics, OEM, Molecular Technology, Biosecurity, Life Sciences, Food Safety, Nucleic Acid Amplification, Molecular Assays, Biotechnology, and Nanotechnology Type: | 1 | 33 |
 | IFPMA We represent the innovative pharmaceutical industry globally, with a focus on innovation, equitable access, and ethics. IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere. To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health. Biopharmaceuticals, … Type: | 42 | 69 |
 | PB&B Facial & Body Remodeling Technology for Medical Aesthetics PB&B Ltd. is a specialty Swiss Life Sciences company founded by bioengineers working with plastic surgeons & dermatologists to test and bring to market a new patented injectable technology for the remodeling of soft tissues of the face & body. PBB-002 enhances adipocytes' volume with fatty acids, as to provide natural & longer-term results with the highest level of safety. PB&B’s patented technology aims to transform a fast growing, multi-billion-dollar facial aging & body remodeling markets with the next generation of injectables in Medical Aesthetics. Aesthetics, Facial rejuvenation, Breast augmentation, Buttock augmentation, … Type: | 0 | 4 |
 | Piomic Medical Advanced wound care, made personal. There are about 50 million reported cases of patients suffering from hard-to-heal wounds, which has created a severe cost burden on global healthcare systems. Piomic develops innovative medical devices for the treatment of hard-to-heal wounds. The COMS® One Therapy System is a portable, hand-held device that incorporates the technologies for optical and magnetic stimulation, intended to promote wound healing in chronic leg and foot ulcers. It integrates smoothly into the patient’s healing journey with usage in all care environments. By developing a therapy that is safe and effective we hope to set a better future … Type: | 1 | 17 |
 | Cocoon Bioscience Proteins For Sustainability Cocoon Bioscience specializes in the manufacturing of high performance growth factors and enzymes using an automated platform leveraging cocooned insects as natural, low cost bioreactors. Type: | 2 | 37 |
 | GLOX Therapeutics Ltd. Precision Protein Antibiotics Glox Therapeutics Ltd. is developing novel precision antibiotics based on protein bacteriocins, which have potent narrow-spectrum activity to target Gram-negative Antimicrobial Resistant (AMR) pathogens. Type: | 0 | 7 |
 | Dompé We Embrace the Challenge in Science Dompé farmaceutici is an international biopharmaceutical company involved in all activities of the pharmaceutical value chain, from research to development, production and marketing. As a long-established family company, we blend the stability that comes from our 130-year heritage with the agility and dynamism of a start-up. We can turn transformative breakthroughs into treatments because we have the right qualities and capabilities to deliver new drugs. Our 160,000 square meter R&D and production site in L’Aquila, Italy, is the heart of Dompé. Here, we conduct vital research, and produce and distribute our primary care and … Type: | 26 | 1,007 |
 | Sterling Pharma Solutions Sterling Pharma Solutions is a leading provider of API services to the pharmaceutical industry. Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) with 50+ years’ experience in providing small molecule API development and manufacturing services to the pharmaceutical industry, specialising in handling challenging chemistries. Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) development and manufacturing services. Sterling believes that while science can be complex, partnerships should be simple. That’s why they have redefined the CDMO experience, marked by transparency, collaboration and trust; … Type: | 4 | 908 |
 | Auto21 Cars and mobility of the 21st century Type: | 1 | N/A |
 | Lymphatica Medtech Lymph Flow Matters Lymphatica develops medical devices for treatment of lymphatic diseases. Born in 2017 as a spin-off of 2 leading Swiss universities, our first product is intended to bring a terrific improvement in quality of life for lymphedema patients: LymphoDrain, the first implantable artificial lymphatic vessels, is a medical device intended to recirculate lymph inside the patient body, re-establishing the physiological fluid equilibrium. Type: | 4 | 13 |
 |  Aerogabs Aerogabs is a consulting service for Entrepreneurs and Small & Medium Business. We boost your Company Performance by designing a Culture of Innovation. We have over 15 years of experience with a strong expertise in high-tech industries such as aerospace and medical devices. We offer 3 solutions: 1-Singularity - understands the dynamic of your territory and then adapt your posture in order to maximize your customer benefits. 2-Strategy - leverages your customer benefits by fully exploiting your potential and reducing the competitive threats. 3-Adocacy - assists you in the implementation of your actionnable plan to boost your venture performance. Please … Type: | 0 | 1 |
 | Polyneuron Pharmaceuticals AG Precision treatment of immune disorders Polyneuron is a growing Basel-based biotechnology company active in the area of autoimmune disease treatments. The company was founded in 2014 as a spinout company from the University of Basel to develop novel treatments to combat immune disorders using its Antibody-CatchTM technology platform. The company currently employs about 10 people and has raised a significant amount in equity funding from top-tier VCs. We are a team of passionate and experienced scientists, entrepreneurs and investors willing to bring new therapies to patients. Type: | 2 | 4 |
 | TWIICE Enabling people to reconnect with their community by giving back access to life. TWIICE is an early stage start-up based in Lausanne, Switzerland. We develop and build customer-specific exoskeletons for walking assistance and rehabilitation of people with mobility issues. Our goal is to give back users the sensations and benefits of standing and walking as well as help them regain some independence in their daily activities. Type: | 7 | 9 |
 | Mindi Independent Health Curator Guiding regular people into Curated Independent Healthcare, giving exclusive access to uncensored content, the very best independent medical professionals, and the most advanced treatments with no wait and extreme privacy. Telehealth, Advanced Therapeutics, Medical Content, Prescriptions, Exclusive Clinic Access, Women's Health, Men's Health, and COVID-19 Type: | 0 | 15 |
 | Neurentis plc NEW FRONTIERS IN NEUROSCIENCE Expertise, Experience, Innovation, Vision, Values. Neurentis PLC is a late-clinical stage UK biotech company, focusing on neuroscience and specialising in the development of novel treatments for mental health and other neurological and psychiatric diseases. Our product pipeline is balanced with 3 products: 1) an advanced lead drug candidate, a prescription pharmaceutical (selegiline), in a transdermal patch, for the treatment of Treatment-Resistant Depression (TRD) in the last stages of drug development, 2) a small molecule agonist of the oxytocin receptors for the treatment of Autism, Chronic and Neuropathic Pain and addiction to alcohol and opioids and 3) … Type: | 1 | 4 |
 | Mewery The first European startup cultivating pork meat on a proprietary microalgae base Mewery is the first European foodtech startup developing cultivated pork on microalgae base. Thanks to Mewery, people all over Europe, Asia and further will be able to enjoy real pork meat, juicy and healthy, but with one huge difference: without having to kill a single pig or harming the planet. Mewery is using their own hybrid culture medium with microalgae extracts and developing 3D structures on microalgae scaffolds. pork cell lines, culture media, proprietary growth factors, microalgea expertise, cultivated pork product line, cellular agrculture, and cell-based meat Type: | 5 | 9 |
 | GlycoEra AG Advancing Glycan Mediated Therapy GlycoEra is positioned as the leading precision protein degradation company. Bifunctional biologics (G-LyTACs), designed by our novel and proprietary technology bind to disease-causing proteins and transport them to the lysosome using naturally occurring endocytic receptors. The disease-causing proteins are degraded in the lysosome and removed from the body. Unlike intracellular protein degraders, like PROTACs and molecular glues, our technology can access targets that are extracellular and membrane proteins, thereby opening up novel targets and therapeutic areas for intervention. Glycoengineering, Therapeutic product development, and Biopharmaceutical CMC development Type: | 1 | 34 |
 | RIBOPRO Dream ahead. RIBOPRO is an innovative service provider, producing high-quality, high-performance RNA products, which are used as powerful research tools and therapeutics. RiboPro offers both off-the-shelf and custom RNA products at competitive rates and turn-around times, effectively removing all barriers to successful use of RNA in the research and development of our customers. We have more than a decade of experience satisfying the RNA-related needs of almost 300 customers worldwide and thus we are confident that we can help you get your next project off to a good start. Let us worry about the quality and performance of your RNA, … Type: | 0 | 27 |
Startup